Cancer Center

Dr. Lane Rosen to Present Radiosurgery Paper at National Oncology Meeting

October 26, 2012

Lane R. Rosen, M.D.Lane R. Rosen, M.D., medical director of radiation oncology at the Willis-Knighton Cancer Center, will be presenting at the American Society for Radiation Oncology (ASTRO) 54th annual meeting in Boston next week. Dr. Rosen's studies were selected from a record-breaking 3,027 abstracts to be presented at ASTRO's 2012 annual meeting, which is the largest research meeting of radiation oncology specialists in the world.

Rosen will present “Monitoring the Response of Stereotactic Body Radiotherapy (SBRT) in Patients With Early-stage Lung Cancer Using Serial Positron Emission Tomography (PET).” This study monitors response in patients who have had radiosurgery in the lung and the success of Willis-Knighton’s approach, which has been developed and refined over the past decade.

He will also present “An Optimization Study and Comparison of a Multichannel Vaginal Cylinder vs. Single Channel Cylinder Applicator in High-dose-rate Brachytherapy.” This study examines the distribution of radiation dose during gynecologic brachytherapy (internal radiation therapy). Over 700 brachytherapy cases were performed at Willis-Knighton (WK) in the past year. Dr. Rosen and his partners at WK routinely instruct physicians from around the country on techniques for performing brachytherapy.

ASTRO is the largest radiation oncology society in the world, with more than 10,000 members who specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, biology and physics, the society is dedicated to improving patient care through education, clinical practice, advancement of science and advocacy.

The addition of a proton therapy center now under construction at the Willis-Knighton Cancer Center will require the expertise and leadership that Willis-Knighton's radiation oncologists have developed I've the past 15 years. Willis-Knighton proton therapy is the next era of guided radiation, delivering pencil-beam scanning and Intensity Modulated Proton Therapy (IMPT) technology to tumors. The proton therapy system at Willis-Knighton will be the first of its kind in the world.

Back to News Releases